ArticleInvestigational new drugs2020
A phase Ib study of a PI3Kinase inhibitor BKM120 in combination with panitumumab in patients with KRAS wild-type advanced colorectal cancer.
Rachel Goodwin et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this papercites it